זימקסיד
allergan israel ltd - gatifloxacin 0.5 %w/v - ophthalmic solution - gatifloxacin - zymaxid is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: aerobic gram- negative bacteria : haemophilus influenzae, aerobic gram-positive bacteria: staphylococcus aureus, staphylococcus epidermidis, streptococcus mitis group*, streptococcus oralis *, streptococcus pneumoniae. efficacy for this organisms was studied in fewer than 10 infections.
zymaxid
allergan israel ltd - gatifloxacin 0.5 %w/v - ophthalmic solution - gatifloxacin - zymaxid is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: aerobic gram- negative bacteria : haemophilus influenzae, aerobic gram-positive bacteria: staphylococcus aureus, staphylococcus epidermidis, streptococcus mitis group*, streptococcus oralis *, streptococcus pneumoniae. efficacy for this organisms was studied in fewer than 10 infections.
zymar ophthalmic solution 0.3%
abbvie pte. ltd. - gatifloxacin - solution - 3 mg/ml - gatifloxacin 3 mg/ml
tymer 0.3% eye drop eye drops
jamjoom pharmaceuticals company, saudi arabia - gatifloxacin - eye drops - 0.3 %
zymar 0.3% ophthalmic solution
allergan pharmaceuticals ltd - gatifloxacin - ophthalmic solution - 0.3 %
gatistar as sesquihydrate 0.3%
مستودع ادوية النابلسي - nabulsi drug store - gatifloxacin as sesquihydrate 0.3 % - as sesquihydrate 0.3%